Biomarker Detects Hepatocellular Carcinoma in Liver Cirrhosis
July 30, 2022
Researchers developed an artificial intelligence-based process to differentiate hepatocellular carcinoma (HCC) from cirrhotic tissues and investigated potential biomarkers that may predict the risk of HCC in patients with cirrhosis. continue reading »